Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR441566 plus methotrexate in adults with moderate to severe rheumatoid arthritis
2023-503910-60-00Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 18
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing SAR441566 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response at week 12. Started Feb 2024; status: completed.
02
Drugs
balinatunfib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2023-503910-60-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503910-60-00.